Dr. Vaccaro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9135 SW Barnes Rd, Suite 261
Portland, OR 97225Phone+1 503-216-6300Fax+1 971-828-0118- Is this information wrong?
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2001 - 2004- Duke University HospitalResidency, Internal Medicine, 1998 - 2001
Louisiana State University School of Medicine in New OrleansClass of 1998
Certifications & Licensure
TN State Medical License 2023 - 2026
OR State Medical License 2008 - 2025
NC State Medical License 1998 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Portland Monthly Magazine Castle Connolly, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
- A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein Start of enrollment: 2015 Jul 20
- Join now to see all
Publications & Presentations
PubMed
- Nivolumab Plus Ipilimumab in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Rohatgi, N., Rothe, M., Mangat, P., Garrett-Mayer, E., Meric-Bernstam, F., Pisick, E., Alese, O., Reynolds, C., Thota, R., Vaccaro, G., von Mehren, M., Arend, R., Chiu...> ;JCO Precision Oncology. 2023 Sep 1
- Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal ...Emerson Y Chen, Adel Kardosh, Nima Nabavizadeh, Bryan Foster, Skye C Mayo, Kevin G Billingsley, Erin W Gilbert, Christian Lanciault, Aaron Grossberg, Kenneth G Bensch,...> ;Cancer Medicine. 2023 Jun 1
- 3 citationsModulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma.Sinha, M., Betts, C., Zhang, L., Griffith, M., Solman, I., Chen, B., Liu, E., Tamaki, W., Stultz, J., Marquez, J., Sivagnanam, S., Cheung, A., Pener, D., Fahlman, A., ...> ;Journal for Immunotherapy of Cancer. 2023 Jan 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Providence St. Vincent Medical CenterPortland, Oregon
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
